Methadone intermediate
![]() | |
| Systematic (IUPAC) name | |
|---|---|
|
4-cyano-2-dimethylamino-4,4-diphenylbutane | |
| Clinical data | |
| Routes of administration | N/A |
| Legal status |
|
| Identifiers | |
| CAS Number | 125-79-1 |
| ATC code | none |
| PubChem | CID 31331 |
| ChemSpider | 29065 |
| Chemical data | |
| Formula | C19H22N2 |
| Molar mass | 278.391 g/mol |
| |
| |
Methadone intermediate is a methadone precursor scheduled by UN Single Convention on Narcotic Drugs. It is a Schedule II Narcotic controlled substance in the United States and has an ACSCN of 9254. The 2014 annual manufacturing quota was 32 875 kilos.[1]
See also
- Moramide intermediate
- Pethidine intermediate A
- Pethidine intermediate B (norpethidine)
- Pethidine intermediate C (pethidinic acid)
References
This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
